Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gregory W. Schafer currently holds 254,062 shares of Nile Therapeutics, Inc. (NILT.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory W. Schafer has been a net seller of NILT.OB stock. They have purchased $33.9K and sold $5.8M worth of shares.
Gregory W. Schafer's most recent insider trade was on Jan 25, 2018, when they sold 3,317 shares at $0.00 per share.
Gregory W. Schafer serves as Executive at Nile Therapeutics, Inc. (NILT.OB). They have executed 58 insider transactions totaling $5.9M over their tenure at the company.
Gregory W. Schafer holds the position of Executive at Nile Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Gregory W. Schafer has shown a selling trading pattern, with $33.9K in total purchases and $5.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gregory W. Schafer was on Nov 10, 2016, when they sold $734.9K worth of ADRO shares. This transaction involved 49,856 shares at $14.74 per share.
Gregory W. Schafer currently owns 254,062 shares of Nile Therapeutics, Inc. (NILT.OB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gregory W. Schafer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gregory W. Schafer has 58 Form 4 filings on record as an insider at Nile Therapeutics, Inc..
Set alerts for Gregory W. Schafer and 40,000+ other insiders.